Use of biomarkers in the context of orphan medicines designation in the European Union

Overview of attention for article published in Orphanet Journal of Rare Diseases, January 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

policy: 3 policy sources

twitter: 1 X user

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 28 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 3 policy documents that reference this research output.

Effects of supplementary protection mechanisms for pharmaceutical products

Cited by rijksoverheid.nl on 01 May 2018

rijksoverheid.nl is a searchable database of documents produced by the Dutch government.

Pakketbeheer weesgeneesmiddelen

Cited by overheid.nl on 21 Dec 2015

Overheid.nl is the Dutch government's web portal, allowing access to parliamentary documents and datasets.

Pakketbeheer weesgeneesmiddelen

Cited by Zorginstituut Nederland on 26 Oct 2015

Zorginstituut Nederland (Netherlands Healthcare Institute) is an independent Dutch administrative body that ensures that Dutch citizens are and remain insured in accordance with the Health Insurance Act and the Long-Term Care Act. The Healthcare Institute occupies an independent position between the Ministry of Health, Welfare and Sport, health insurers, care providers and patient organizations.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.